Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inflammatory Breast Cancer (IBC) Registry

NCT00477100 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00477100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00477100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inflammatory Breast Cancer (IBC) Registry
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
April 17, 2007
Completion date
April 30, 2030
Enrollment
1,200 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory breast carcinoma, invasive breast carcinoma, second primary malignant neoplasm